Track Korsana Biosciences, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Korsana Biosciences, Inc. KRSA · Stock Open Korsana Biosciences, Inc. in new tab

34.99 USD
EPS
-7.07
P/B
-4.46
Target Price
35.33 USD
Loading chart...
Key Metrics
Earnings dateNov. 11, 2026
EPS-7.07
Book Value-7.84
Price to Book-4.46
Debt/Equity0.85
% Insiders0.384%
Estimates
Forward P/E-9.84
Forward EPS-3.56
Target Mean Price35.33

DCF Valuation

Tweak assumptions to recompute fair value for Korsana Biosciences, Inc. (KRSA)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Korsana Biosciences, Inc. Logo Korsana Biosciences, Inc. Analysis (KRSA)

US Healthcare Official Website Stock

Is Korsana Biosciences, Inc. a good investment? Korsana Biosciences, Inc. (KRSA) is currently trading at 34.99 USD. Market analysts have a consensus price target of 35.33 USD. This suggests a potential upside from current levels.

Earnings Schedule: Korsana Biosciences, Inc. is expected to release its next earnings report on Nov. 11, 2026. The market consensus estimate for Forward EPS is -3.56.

Investor FAQ

Does Korsana Biosciences, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Korsana Biosciences, Inc.?

Korsana Biosciences, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Nov. 11, 2026. The company currently has a trailing EPS of -7.07.

Company Profile

Korsana Biosciences, Inc., a biotechnology company that discovers and develops novel therapies for neurodegenerative diseases. The company was incorporated in 2024 and is based in Waltham, Massachusetts.

Exchange Ticker
NASDAQ KRSA
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
May 16, 2023 1:20
Sept. 9, 2026 1:7
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion